There are 783 resources available
The role of MTOR/P3K inhibitors
Presenter: Jee Hyun Kim
Session: Optimal management of ER+ and HER-2 negative patients
First-line therapy of IDH-mutated diffuse low grade glioma in an adult patient
Presenter: Jong Hee Chang
Session: Challenging cases: Primary and secondary brain tumours
BRAF mutated glioma in childhood
Presenter: Darren Hargrave
Session: Challenging cases: Primary and secondary brain tumours
Resources:
Slides
Webcast
Leptomeningeal carcinomatosis of solid cancer
Presenter: Yoko Nakasu
Session: Challenging cases: Primary and secondary brain tumours
Resources:
Slides
Webcast
Surgery/RFA
Presenter: Jong Man Kim
Session: Multi-modality treatment approach in HCC
Predictive immunotherapy biomarkers in GU malignancies
Presenter: Laurence Albiges
Session: Immunotherapy in GU malignancies
Resources:
Slides
Webcast
1802 - Final Results of Phase I Trial of HF10, Oncolytic Virus Immunotherapy, in Japanese Patients with Refractory Superficial Cancers (382O)
Presenter: Naoya Yamazaki
Session: Melanoma
Resources:
Abstract
Slides
Webcast
Metastatic disease / relapse
Presenter: Takuji Okusaka
Session: Multi-modality treatment approach in HCC
Resources:
Slides
Intravesicle therapy in early bladder cancer: immunotherapy to the fore again
Presenter: Teik Aik Ong
Session: Immunotherapy in GU malignancies
Immunotherapy in GU malignancies - Conclusions and clinical perspectives
Presenter: Laurence Albiges
Session: Immunotherapy in GU malignancies
Resources:
Slides
Webcast